Allosteric modulators for
human health
About us
Addex Corporate Presentation
Overview
Our people
Executive Officers
Non-Executive Directors
Contact
Privacy Policy
Careers
Pipeline
Clinical and Pre-Clinical Pipeline
Research And Development
Technology
Allosteric modulation
Publications
Partners & collaboration
Investors
Addex corporate Presentation
Stock Data
Press releases
Ad hoc announcements (Art. 53 L.R)
Events
Financial Reports
Analyst Reports
General Meetings
SEC / SIX Filings
Guide to US ADSS for Six Shareholders
Register for email news
Corporate Governance
Contact
Media
Press releases
Contact
Press releases
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Please select year
03.10
2022
Addex Reports Full Year 2021 Financial Results and Provides Corporate Update
03.07
2022
Addex Therapeutics to Release Full-Year 2021 Financial Results and Host Conference Call on March 10, 2022
02.24
2022
Addex to Present at the Virtual Sachs Associates 3rd Annual European HealthTech and 15th Annual European Life Sciences CEO Forums
02.03
2022
Addex Increases Issued Share Capital to Create Treasury Shares
01.11
2022
Addex to Present at the Swiss Equities Baader Virtual Conference
01.06
2022
Addex to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
12.17
2021
Addex Raises $10.0 Million in Equity Financing
12.15
2021
Addex Provides Year End Pipeline Development Update
11.18
2021
Addex to Present at the Virtual German Equity Forum
11.15
2021
Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
Next
Back